Nanogen Posts 134-Percent Q3 Revenue Growth as Losses Rise 34 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Nanogen yesterday reported that third-quarter revenues bolted upwards 134 percent on dramatic increases in product sales, but the company posted a 34-percent increase in net loss.
Total receipts for the quarter ended Sept. 30 increased to $7.5 million from $3.2 million year over year.
R&D spending in the quarter doubled to $6.2 million, Nanogen said.
Nanogen said net losses for the period swelled to $11.8 million from $8.8 million year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.